跳至主要内容
临床试验/JPRN-UMIN000052064
JPRN-UMIN000052064招募中3 期

obectomy versus Segmentectomy for Clinical Stage IA3 Pure-solid Non-small Cell Lung Cancer: a Phase III Randomized Trial (STEP UP trial) (WJOG 16923L) - Lobectomy versus Segmentectomy for Clinical Stage IA3 Pure-solid Non-small Cell Lung Cancer: a Phase III Randomized Trial (STEP UP trial) (WJOG 16923L)

West Japan Oncology Group0 个研究点目标入组 520 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
520

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of synchronous or metachronous (within 2 years) malignancies with 5-year relative survivals of less than 95% at the time of diagnosis. 2) Local or systemic active infection requiring treatment. 3) Pregnant, lactating, possibly currently pregnant. 4) Psychosis. 5) Systemic administration of steroids or immunosuppressive agents. 6) Patient who has severe drug allergy. 7) Comorbidities (i) Diagnoses of interstitial pneumonia, pulmonary fibrosis, or severe pulmonary emphysema. (ii) Uncontrollable diabetes (HbA1c > 8%). (iii) Uncontrollable hypertension. (iv) Unstable angina or history of myocardial infarction within 6 months prior to enrollment. (v) Uncontrollable heart valve disease, dilated cardiomyopathy, or hypertrophic cardiomyopathy.

研究者

相似试验

obectomy versus Segmentectomy for Clinical Stage IA3... | 临床试验